Allmed Medical Products Co.,Ltd (SHE:002950)
China flag China · Delayed Price · Currency is CNY
10.94
-0.01 (-0.09%)
At close: Feb 13, 2026

SHE:002950 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
3,4403,2932,7074,1952,8883,796
Other Revenue
33.1233.1249.415.7837.4438.58
3,4733,3262,7574,2112,9263,834
Revenue Growth (YoY)
8.92%20.66%-34.53%43.92%-23.70%63.00%
Cost of Revenue
2,4532,3982,0992,8122,0532,224
Gross Profit
1,020928.04657.931,399872.171,610
Selling, General & Admin
362.11374.65386.38446.53367.52286.51
Research & Development
125.11106.3777.37107.7494.58118.13
Other Operating Expenses
14.0810.4913.8226.4719.134.81
Operating Expenses
499.23494.41478.51582.45484.52410.9
Operating Income
520.74433.64179.42816.21387.651,200
Interest Expense
-14.44-25.53-31.87-35.47-17.18-17.66
Interest & Investment Income
9.427.161.873.0939.9750.58
Currency Exchange Gain (Loss)
17.1517.15-8.57-140.6333.4123.62
Other Non Operating Income (Expenses)
1.86-1.27-2-6.3-6.34-0.92
EBT Excluding Unusual Items
534.73431.15138.85636.9437.511,255
Gain (Loss) on Sale of Investments
-17.08-23.28-6.88-160.196.130.48
Gain (Loss) on Sale of Assets
29.3728.79-0.073.51.9426.34
Asset Writedown
-21.41-9.140.5-16.8-0.12-0.08
Other Unusual Items
26.226.8736.6521.4959.7956.54
Pretax Income
551.81454.39169.04484.9505.491,339
Income Tax Expense
93.8285.5964.8380.2673.53178.2
Earnings From Continuing Operations
458368.8104.22404.64431.961,160
Minority Interest in Earnings
-5.68-0.126.182.15-0.75-2.94
Net Income
452.32368.68110.4406.79431.211,158
Net Income to Common
452.32368.68110.4406.79431.211,158
Net Income Growth
100.89%233.95%-72.86%-5.66%-62.75%255.27%
Shares Outstanding (Basic)
629625633633632633
Shares Outstanding (Diluted)
629625633633632633
Shares Change (YoY)
0.15%-1.33%0.02%0.17%-0.05%2.81%
EPS (Basic)
0.720.590.170.640.681.83
EPS (Diluted)
0.720.590.170.640.681.83
EPS Growth
100.59%238.44%-72.87%-5.82%-62.73%245.58%
Free Cash Flow
565.96554.64137.02751.6884.161,193
Free Cash Flow Per Share
0.900.890.221.190.131.89
Dividend Per Share
0.0600.0600.0270.0600.2100.880
Dividend Growth
122.22%122.22%-55.00%-71.43%-76.14%120.00%
Gross Margin
29.37%27.90%23.87%33.22%29.81%42.00%
Operating Margin
14.99%13.04%6.51%19.38%13.25%31.28%
Profit Margin
13.03%11.08%4.00%9.66%14.74%30.19%
Free Cash Flow Margin
16.30%16.68%4.97%17.85%2.88%31.12%
EBITDA
751.53661.52403.431,008532.771,342
EBITDA Margin
21.64%19.89%14.64%23.95%18.21%34.99%
D&A For EBITDA
230.78227.88224192.2145.12142.22
EBIT
520.74433.64179.42816.21387.651,200
EBIT Margin
14.99%13.04%6.51%19.38%13.25%31.28%
Effective Tax Rate
17.00%18.84%38.35%16.55%14.55%13.31%
Revenue as Reported
3,4733,3262,7574,2112,9263,834
Advertising Expenses
-17.9715.98-27.18.91
Source: S&P Global Market Intelligence. Standard template. Financial Sources.